Influence of phospholipids on the assessment of factor VIII activity

Haemophilia

Volumn 4, Issue 4, 1998, Pages 646-650

  Mikaelsson, M ^a   Oswaldsson, U ^a   Sandberg, H ^a  

^a PFIZER INC   (United States)

Author keywords

Assays; Chromogenic; Factor VIII; Haemophilia A; One stage; Phospholipids

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; CHROMOGENIC SUBSTRATE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; REAGENT; RECOMBINANT BLOOD CLOTTING FACTOR 8; THROMBOPLASTIN;

BLOOD CLOTTING TIME; CONFERENCE PAPER; CONTROLLED STUDY; DILUTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; HEMOPHILIA A; HUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA; PRIORITY JOURNAL;

EID: 0031878077     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.440646.x     Document Type: Conference Paper

References (15)

1. Barrowcliffe TW. Standardization and assay. Semin Thromb Haemost 1993; 19: 73-9.
2. Barrowcliffe TW. Recommendations for the assay of high-purity factor VIII concentrates. Thromb Haemostas 1993; 70: 876-7.
3. Barroweliffe T. Potency issues with recombinant factor VIII. Ann Hematol 1994; 68: S89-S91.
4. Mikaelsson M, Oswaldsson U, Nilsson IM. Potency and in vivo recovery of high purity factor VIII concentrates. Thromb Haemostas 1994; 72: 160-1.
5. Prowse CV. In vivo recovery of factor VIII following transfusion: A survery of recent data and publications to assess the influence of standards used for potency assignment. Thromb Haemostas 1995; 74: 1191-6.
6. Lee C, Barrowcliffe T, Bray G, Gomperts E, Hubbard A, Kemball-Cook G, et al. Pharmacokinetic in vivo comparison using 1-stage and chromogenic substrate assays with two formulations of Hemofil M. Thromb Haemostas 1996; 76: 950-6.
7. Lusher JM, Hillman-Wiseman C, Simpson P, Hurt D. Plasma FVIII levels measured after infusion of recombinant FVIII (RFVIII) vary significantly with different assay methods (will the real FVIII level please stand-upl). Blood 1995; 86 (Suppl. 1): Abstract 755.
8. Lee C, Owens D, Lilley P, Giangrande P, Collins P, Hay C, et al. In vivo pharmacokinetics of recombinant factor VIII (Recombinate) using one stage clotting and chromogenic factor VIII assay. Blood 1997; 90 (Suppl. 1): Abstract 143.
9. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959; 234: 466-8.
10. Mikaelsson M, Oswaldsson U, Frank L. Unpublished data on file. Pharmacia & Upjohn AB 1998.
11. Nilsson IM, Blomback M, Francken von I. On an inherited autosomal hemorrhagic diathesis with antihaemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 159: 35-7.
12. Barrowcliffe TW, Gray E. Studies of phospholipid reagents used in coagulation 1: Some general properties and their sensitivity to factor VIII. Thromb Haemostas 1981; 46: 629-3.
13. Stevenson KJ, Easton AC, Curry A, Thomson JM, Poller L. The reliability of activated partial thromboplastin time methods and the relationship to lipid composition and ultrastructure. Thromb Haemostas 1986; 55: 250-8.
14. Sandberg H, Andersson L-O, Höglund S. Isolation and characterization of lipid protein particles containing platelet factor 3 released from human platelets. Biochem J 1982; 203: 303-11.
15. Sekiya F, Yoshida M, Yamashita T, Morita T. Magnesium (II) is a crucial constituent of the blood coagulation cascade. J Biol Chem 1996; 271: 8541-4.